Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Compound 4 is a promising treatment for hair loss with low toxicity.

Mitoquinone protects heart cells from doxorubicin damage and slightly boosts its effect on prostate cancer cells.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Applying certain inhibitors to the skin can promote hair growth without harming cells.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

The treatment combination is effective and generally safe for lung cancer.

Removing a methyl group from the ITGAV gene speeds up bone formation in a specific type of bone disease model.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

Chemotherapy-induced hair loss may be linked to immune system changes, and certain treatments could help but need careful use.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

These new skin treatments are safer and more effective with minimal side effects.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

A new anti-baldness patch effectively treats hair loss by blocking enzymes linked to the condition.

A new method efficiently creates biaryl N-oxides with potential for cancer treatment and drug development.

Plerixafor may help restore skin pigmentation safely.

Two distinct pathways direct proteins to vacuoles in Arabidopsis, affecting root hair growth and protein targeting.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Isoquercitrin helps hair grow by activating certain cell processes.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.